Denali Therapeutics Inc Revenue per Employee (DNLI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Denali Therapeutics Inc   (NASDAQ: DNLI)
 

Denali Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Denali Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 42,509, but the productivity of Denali Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Denali Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Denali Therapeutics Inc has 503 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNLI Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 42,509 7,165 - - -
DNLI's Total Ranking # # # # #
Seq. Revenue Change 393.29 % - - - -

DNLI Company Profile >> Back to DNLI Efficiency Comparisons >> Compare DNLI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 709,881 $ 310,863 $ 1,274
(Jun 30 2021)   (Mar 31 2018)



Financial Statements
Denali Therapeutics Inc 's Revenue MRQ $ 18 Millions Visit DNLI's Income Statement
Denali Therapeutics Inc 's Revenues TTM $ 21 Millions Visit DNLI's aggregate revenue growth
What are DNLI's Sales? Visit DNLI's Sales by Segment




Other Ratios
Denali Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DNLI's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DNLI's Competitors
Revenue per Employee for DNLI's Suppliers
Revenue per Employee for DNLI's Customers

You may also want to know
DNLI's Sales Growth Rates DNLI's Pe Price to earnings ratio DNLI's Receivables Turnover Ratio DNLI's Stock Quote
DNLI's Net Income Growth Rates DNLI's Ps Price to Sales ratio DNLI's Sales per Employee DNLI's Asset Turnover Ratio
DNLI's Net Margin DNLI's Pb Price to Book ratio DNLI's Financial Strength Ratios DNLI's Dividend Payout Ratio
Date modified: 2026-11-04T16:54:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Lucid Diagnostics Inc   66,304.88 $ 5.437  Million 82 
Metagenomi Therapeutics Inc   59,546.22 $ 7.086  Million 119 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 
Prime Medicine Inc   48,363.01 $ 7.061  Million 146 
Volitionrx Limited  45,928.57 $ 3.445  Million 75 
Vivos Inc  45,799.50 $ 0.092  Million 2 
Upstream Bio Inc   38,266.67 $ 2.870  Million 75 
Nexalin Technology Inc   34,663.37 $ 0.277  Million 8 
Alumis inc   32,316.96 $ 7.239  Million 224 
Longeveron Inc   30,657.89 $ 1.165  Million 38 
Dbv Technologies S a   22,611.76 $ 3.844  Million 170 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.